Inhibition of Akt with small molecules and biologics: historical perspective and current status of the patent landscape

Author： Mattmann Margrith E Stoops Sydney L Lindsley Craig W

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.21, Iss.9, 2011-09, pp. : 1309-1338

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic potential of FtsZ inhibition: a patent perspective

By Awasthi Divya Kumar Kunal Ojima Iwao

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 5, 2011-05 ,pp. : 657-679

Informa Healthcare

Access to resources Recommend Favorite

Current patent status of histone deacetylase inhibitors

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 9, 2002-09 ,pp. : 1375-1384

Informa Healthcare

Access to resources Recommend Favorite

Current Treatment of Psoriasis with Biologics

Current Drug Discovery Technologies, Vol. 6, Iss. 4, 2009-12 ,pp. : 231-240

Bentham Science Publishers

Access to resources Recommend Favorite

Current perspective on differential communication in small resistance arteries

By Tran Cam Ha T. Welsh Donald G.

Canadian Journal of Physiology and Pharmacology, Vol. 87, Iss. 1, 2009-01 ,pp. : 21-28

NRC Research Press

Access to resources Recommend Favorite

Inhibition of Tumor Angiogenesis by Antibodies, Synthetic Small Molecules and Natural Products

Current Medicinal Chemistry, Vol. 18, Iss. 21, 2011-07 ,pp. : 3136-3155

Bentham Science Publishers

Access to resources Recommend Favorite